Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Franklin Strategic Series - Franklin Biotechnology Discovery Fund

+ Add to Watchlist

FBDIX:US

198.97 USD 3.77 1.93%

As of 09:29:30 ET on 05/27/2015.

Snapshot for Franklin Strategic Series - Franklin Biotechnology Discovery Fund (FBDIX)

Year To Date: +18.03% 3-Month: +6.02% 3-Year: +42.50% 52-Week Range: 127.11 - 205.77
1-Month: +3.60% 1-Year: +55.83% 5-Year: +34.48% Beta vs SPX: 1.05

Mutual Fund Chart for FBDIX

No chart data available.
  • FBDIX:US 198.97
  • 1M
  • 1Y
Interactive FBDIX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBDIX

Franklin Biotechnology Discovery Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The Fund invests a substantial portion of its assets in equity securities of smaller capitalization companies.

Inception Date: 09-15-1997 Telephone: (800) 632-2350
Managers: EVAN MCCULLOCH / JEREL BANKS
Web Site: www.franklintempleton.com

Fundamentals for FBDIX

NAV (on 2015-05-27) 198.97
Assets (M) (on 2015-04-30) 1,846.09
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment -

Dividends for FBDIX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-12-15) 3.73
Dividend Yield (ttm) 3.35

Fees & Expenses for FBDIX

Front Load 5.75
Back Load 0.00
Current Mgmt Fee 0.59
Redemption Fee 0.00
12b1 Fee 0.30
Expense Ratio 1.10

Top Fund Holdings for FBDIX

Filing Date: 03/31/2015
Name Position Value % of Total
Celgene Corp 1,462,700 168,620,056 8.521%
Biogen Inc 351,461 148,400,893 7.499%
Gilead Sciences Inc 1,177,000 115,499,010 5.836%
Amgen Inc 562,600 89,931,610 4.544%
Puma Biotechnology Inc 278,244 65,696,191 3.320%
Incyte Corp 711,800 65,243,588 3.297%
BioMarin Pharmaceutical Inc 489,756 61,033,393 3.084%
Medivation Inc 464,554 59,959,985 3.030%
Regeneron Pharmaceuticals Inc 132,209 59,689,719 3.016%
Illumina Inc 280,200 52,016,328 2.628%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil